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development of the facial motor nucleus 
and the establishment of the facial nerves
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Abstract 
Background: Axons from the visceral motor neurons (vMNs) project from nuclei in the hindbrain to innervate 
autonomic ganglia and branchial arch-derived muscles. Although much is known about the events that govern 
specification of somatic motor neurons, the genetic pathways responsible for the development of vMNs are less well 
characterized. We know that vMNs, like all motor neurons, depend on sonic hedgehog signaling for their generation. 
Similarly, the paired-like homeobox 2b (Phox2b) gene, which is expressed in both proliferating progenitors and post-
mitotic motor neurons, is essential for the development of vMNs. Given that our previous study identified a novel 
role for the short stature homeobox 2 (Shox2) gene in the hindbrain, and since SHOX2 has been shown to regulate 
transcription of islet 1 (Isl1), an important regulator of vMN development, we sought to determine whether Shox2 is 
required for the proper development of the facial motor nucleus.
Results: Using a Nestin-Cre driver, we show that elimination of Shox2 throughout the brain results in elevated cell 
death in the facial motor nucleus at embryonic day 12.5 (E12.5) and E14.5, which correlates with impaired axonal 
projection properties of vMNs. We also observed changes in the spatial expression of the vMN cell fate factors Isl1 and 
Phox2b, and concomitant defects in Shh and Ptch1 expression in Shox2 mutants. Furthermore, we demonstrate that 
elimination of Shox2 results in the loss of dorsomedial and ventromedial subnuclei by postnatal day 0 (P0), which may 
explain the changes in physical activity and impaired feeding/nursing behavior in Shox2 mutants.
Conclusions: Combined, our data show that Shox2 is required for development of the facial motor nucleus and its 
associated facial (VII) nerves, and serves as a new molecular tool to probe the genetic programs of this understudied 
hindbrain region.
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Background
In the hindbrain, motor neuron progenitors are born in 
a region-specific manner, neighboring the floor plate, 
in response to their level of exposure to different mor-
phogenetic gradients [1, 2]. These neuronal progenitors 
differentiate in a rhombomere-specific pattern, which 
requires the correct spatiotemporal expression of the 
homeotic (Hox) gene clusters [3–6]. Motor neuron pro-
genitors in the hindbrain can differentiate into somato-
motor neurons (sMNs), which innervate the skeletal 
muscles of the body, or visceromotor neurons (vMNs), 
which innervate autonomic ganglia (general vMNs) and 
branchial arch-derived muscles (special vMNs) [3, 7, 8]. 
Facial (VII) motor neurons, which originate from rhom-
bomeres 4/5, belong to the vMN class of motor neurons. 
At embryonic day 11.25 (E11.25), facial motor neurons 
begin to migrate caudally to the pial side of the hindbrain 
to form the facial motor nucleus, which subsequently 
segregates into two lobes [6, 9, 10]. Despite the elucida-
tion of the genetic mechanisms that specify sMN identity, 
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the corresponding pathways responsible for the estab-
lishment of vMNs are less well understood. Furthermore, 
even though sonic hedgehog (SHH) signaling is known to 
be required for the development of all motor neurons [7, 
11–15], the upstream regulators of Shh expression and 
function during late embryonic and early postnatal devel-
opment, especially within the vMNs of the facial motor 
nucleus, remain largely unknown [16].
The paired-like homeobox 2b (Phox2b) gene is 
expressed in both proliferating progenitors and post-
mitotic motor neurons and is required for the develop-
ment of vMNs [17, 18]. Similarly, the homeodomain 
transcription factor islet1 (ISL1), which is expressed in 
both post-mitotic sMNs and vMNs, plays a broad role 
in motor neuron identity and specification [7, 8, 17, 19, 
20]. In the absence of Isl1, mice die during embryogenesis 
around E11.5. This embryonic lethality is associated with 
an increase in cell death in the hindbrain and neural tube, 
suggesting that loss of Isl1 function results in the death of 
cells that were fated to differentiate into motor neurons 
[19]. In the trigeminal and dorsal root ganglia (DRG), Isl1 
appears to play distinct roles during early (i.e. neurogen-
esis) versus late (i.e. subtype specification) development 
[21]. In cranial ganglia, Isl1 is required for cell survival 
and Isl1 mutants show thinner blunted facial (VII) gan-
glia [22]. However, the precise role of Isl1 in these cell 
types and in their respective hindbrain nuclei, such as the 
facial motor nucleus, remains poorly documented.
The adult facial motor nucleus contains seven subnu-
clei; the lateral, dorsolateral, dorsal intermediate, ventral 
intermediate, dorsomedial and ventromedial nuclei are 
located within the main nucleus, while the seventh, the 
dorsal accessory nuclei, is located above the main nucleus 
[23, 24]. Neurons innervating the nasolabial musculature 
are located in the lateral facial motor nucleus, while neu-
rons supplying the auricular musculature are located in 
the medial facial motor nucleus [23, 24]. Together the 
lateral, intermediate and medial subnuclei comprise 43, 
27.1, and 28.7%, respectively, of the motor neurons in 
the adult facial motor nucleus, with the dorsal accessory 
nuclei contributing the final 1.2% [23].
Studies with mouse knockout models have shown 
that Shox2 is required for normal development of the 
humerus and femur [25–27], the anterior palate [28], the 
temporomandibular joint of the jaws [29], the sinoatrial 
valves and pacemaker region of the heart [30, 31], and 
TrkB-positive mechanosensory neurons of the dorsal 
root ganglia [32]. Most recently, Shox2 has been shown 
to play an important role in development of the inferior 
colliculus and cerebellum [33]. We suspected a function 
for Shox2 during facial motor nucleus development given 
our previous study demonstrating a novel role for Shox2 
in the hindbrain [33], and since SHOX2 has been shown 
to regulate transcription of Isl1 [34], an important regu-
lator of vMN development [7, 8, 19, 22]. In the current 
study we show that conditional inactivation of Shox2 in 
the brain results in impaired axonal projections of vMNs 
and a concomitant loss of medially located neurons in the 
facial motor nucleus postnatally. Furthermore, we dem-
onstrate that Shox2-mutant neonates display impaired 
feeding behavior, perhaps due to facial paralysis as a 
result of improper development and function of the facial 
nerves.
Results
Shox2 expression in the face and facial motor nucleus 
during development
Whole-mount in  situ hybridization (WISH) at E11.5 
showed Shox2 expression in the trigeminal (V) and facial 
(VII) ganglia, in addition to the developing maxillary 
process and mandibular arch (Figure 1a). Shox2 contin-
ued to be expressed in the trigeminal (V) ganglia, max-
illary process and mandibular arch at E12.5 (Figure 1b). 
We also visualized the Shox2 expression pattern with 
a novel Shox2lacz allele (described in “Methods”). X-gal 
staining of embryos carrying the Shox2lacz allele accu-
rately reproduced the endogenous Shox2 expression 
pattern with increased sensitivity and less background 
compared to WISH (Additional file  1: Figure S1). At 
E10.5, Shox2lacZ/+ embryos showed lacZ staining in the 
trigeminal (V) and facial (VII) ganglia of the embryo 
(Figure  1f ). Similarly at E11.5, lacZ staining was vis-
ible in the trigeminal (V) and facial (VII) nerves of the 
embryo, in addition to the maxillary process and man-
dibular arch (Figure 1g). LacZ continued to be expressed 
in the trigeminal (V) ganglion of the embryonic face 
from E12.5 to E13.5, and could be seen in the developing 
pharyngeal arch (Figure 1h, i). At E14.5 lacZ expression 
was present in the facial mesenchyme that contributes 
to the maxilla and mandible (Figure 1j). However, from 
E12.5 onward lacZ staining was no longer observed 
in the facial (VII) ganglia (Figure  1h–j). Postnatally 
(P0) lacZ expression was maintained in the facial mes-
enchyme surrounding the facial (VII) nerves, but not 
within the axons themselves (Figure 1k). Examination of 
Shox2 expression early embryonically in the developing 
brain showed Shox2 staining in a region of post-mitotic 
neurons adjacent to the floor plate (Additional file 2: Fig-
ure S2A–B), a region where Phox2b+/Isl1+ are localized 
(Additional file  2: Figure S2C–E) [18]. Later in the P0 
brain, Shox2 was expressed in the facial motor nucleus 
(Figure  1c–e). Similarly, in Shox2lacZ/+ animals, lacZ 
staining was strongly expressed in both the lateral and 
medial lobes of the facial motor nucleus (Figure  1l–o); 
however, staining was not visible within the trigeminal 
nucleus (Figure 1n, arrowhead).
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Nestin‑Cre Shox2‑mutant pups exhibit defects in feeding 
behavior
To determine the functional role of Shox2 in the facial 
motor nucleus, we used Nestin-Cre [35] to delete the 
Shox2 gene conditionally in neural tissue throughout 
the central nervous system (CNS). We crossed Nestin-
Cre; Shox2+/− mice with Shox2flox/flox mice [25] to obtain 
conditional mutant Nestin-Cre; Shox2flox/− embryos 
and neonates. Shox2 expression was eliminated in the 
brain of Nestin-Cre Shox2-mutant embryos, including 
the facial motor nucleus (Additional file 3: Figure S3C–
D, dashed-circle). All Nestin-Cre Shox2-mutant pups 
died between 18 to 26  h following birth. This limited 
our characterization of Shox2 function to embryonic 
and neonatal stages. P0 Nestin-Cre; Shox2flox/− mutant 
pups displayed reduced activity and impaired feeding 
behavior as early as 6 h following birth (Additional file 4: 
Movie 1), which correlated with a lack of milk in the 
stomachs of Nestin-Cre; Shox2flox/− mutant pups (Addi-
tional file 3: Figure S3E, arrows). Since Shox2 is required 
for the proper development of the palate [28], we ana-
lyzed the anterior and posterior palate of Nestin-Cre; 
Shox2flox/− mutant pups. We did not observe any obvi-
ous defects or malformations in the palate of Nestin-Cre; 
Shox2flox/− mutant pups (Additional file  3: Figure S3F–
K), suggesting that the absence of milk in Shox2-mutant 
neonatal stomachs was not due to cleft palate malforma-
tions. Nestin-Cre; Shox2flox/− mutant pups also displayed 
tremors 16–26 h following birth (Additional file 4: Movie 
1), which could be related to defects in neural circuitry 
or result from a loss of Shox2 function in other regions 
of the hindbrain.
Figure 1 Shox2 mRNA and lacZ expression in the developing embryonic face and postnatal facial motor nucleus. a, b Whole-mount in situ hybridi-
zation (WISH) at E11.5 (a) and E12.5 (b) show Shox2 expression in the trigeminal (V) and facial (VII, arrow) ganglia, in addition to the developing 
maxillary process (mp) and mandibular arch (ma). c–e In situ hybridization (ISH) on whole P0 brains (c, ventral viewpoint) and sagittal (d) or coronal 
(e) sections through the brain show Shox2 expression in the facial motor nucleus (nVII, arrows). f–j X-gal staining of Shox2lacZ/+ embryos at E10.5 (f), 
E11.5 (g), E12.5 (h), E13.5 (i), and E14.5 (j) shows that Shox2 is expressed in the trigeminal and facial ganglion (f, g, arrow), in addition to the develop-
ing maxillary process and mandibular arch. Starting at E12.5 and continuing to E14.5, Shox2 expression becomes restricted to the trigeminal gan-
glion and the facial mesenchyme that will contribute to the maxilla and mandible, however it is absent from the facial ganglia. k–o X-gal staining 
of Shox2lacZ/+ pups in the P0 face (k), brain (l, side viewpoint; m, ventral viewpoint) and sagittal (n) or coronal (o) sections through the brain show 
Shox2 expression in the tissue surrounding the facial nerves (k), with the exception of the nerves themselves, and Shox2 expression in the facial 
motor nucleus (l–o, arrows). ey eye, nV trigeminal nucleus, sbl superior buccolabial nerve, ibl inferior buccolabial nerve, mm marginal mandibular 
nerve, cb cerebellum, mb midbrain. Scale bar 500 μm.
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Facial (VII) nerve branching defects in Nestin‑Cre 
Shox2‑mutant animals
Since Shox2-mutant neonates displayed impaired feeding 
but an apparently normal palate, we hypothesized that 
Shox2 mutants fail to nurse properly due to facial paraly-
sis. To test this hypothesis, we first sought to determine 
if the abnormal feeding behavior resulted from the loss 
of a subset of axons in the nerves of the face. We stained 
control and Nestin-Cre Shox2-mutant embryos and P0 
heads with the 2H3 antibody that visualizes nerves by 
detecting neurofilaments (Figure 2). In E11.5 Nestin-Cre; 
Shox2flox/− conditional knockout embryos the trigeminal 
nerves (V) appeared normal (Figure  2a–b, arrowheads). 
To confirm that the trigeminal nerves (V) were intact 
even in the complete absence of Shox2, we performed 
neurofilament staining on E11.75 Shox2-null embryos 
(Figure  2c–d, arrowheads) [25]. While the trigeminal 
nerves (V) remained intact, the facial nerves (VII) were 
truncated and failed to branch properly in both Nestin-
Cre; Shox2flox/− conditional knockout and Shox2-null 
embryos (Figure 2a–d, arrows). At E12.5 the facial (VII) 
nerves continued to be truncated as compared to con-
trols (Figure  2e–h, dashed-box). Neurofilament stain-
ing at E12.5 displayed a range in severity of facial (VII) 
nerve truncation, with Figure 2f showing the least severe 
truncation and Figure 2h having the most severe trunca-
tion we observed among seven embryos. Later at E13.5 
(Figure  2i), E14.5 (Figure  2k), and early postnatal (P0; 
Figure  2m) stages, the zygomatic, superior buccolabial, 
inferior buccolabial and marginal mandibular nerve 
branches of the facial (VII) nerve could be seen in con-
trols (Figure 2i, k, m) [36], however these distinct facial 
(VII) nerve branches were truncated or absent in Nestin-
Cre;  Shox2flox/− mutant animals (Figure  2j, l, n; arrows). 
Similar to E12.5, facial (VII) nerve truncation ranged in 
severity at the later embryonic and early postnatal time-
points analyzed (data not shown). The severity in facial 
(VII) nerve truncation observed in Nestin-Cre; Shox-
2flox/− mutant animals, displayed in Figure 2j, l, n, are rep-
resentative of the most common truncations observed.
To confirm the persistent lack of proper facial (VII) 
nerve branching and development, particularly at late 
embryonic and early postnatal time-points when the 
larger head size led to confounding background stain-
ing, we used a second transgenic line, this one carrying 
a bacterial artificial chromosome (BAC) containing the 
Shox2 gene with a lacZ insertion (previously described 
BAC RP23-105B3-lacZ transgenic line [37]) to visualize 
the facial (VII) nerves. While obvious facial (VII) nerve 
truncations were difficult to visualize at E11.5 (Figure 3a, 
b), the main branch of the facial (VII) nerve was notice-
ably truncated, as the smaller ganglionic projections 
were absent at E12.5 in Nestin-Cre; Shox2flox/− mutant 
embryos as compared to controls (Figure  3c–d, arrow). 
Furthermore, consistent with our neurofilament staining, 
at later embryonic (E13.5 and E14.5) and early postnatal 
(P0) stages, the zygomatic, temporal, superior buccola-
bial, inferior buccolabial and marginal mandibular nerve 
branches of the facial (VII) nerve were observed in con-
trols (Figure  3e, g, i) and appeared truncated or absent 
in Nestin-Cre; Shox2flox/− mutant animals (Figure  3f, 
h, j; arrows). For example, by P0 the facial (VII) nerves 
appeared to be absent in Nestin-Cre; Shox2flox/− mutant 
animals (Figure  3j, arrows). The buccal and superficial 
masseter nerves, both sensory components originating 
from the trigeminal (V) nerve [36], were the only nerves 
visible in Nestin-Cre; Shox2flox/− mutant animals, leaving 
the face almost completely devoid of innervation (Fig-
ure  3j, arrows). To determine whether the facial (VII) 
nerve disruptions occurred as a result of the slight reduc-
tion in Shox2 expression in the embryonic facial mes-
enchyme (Additional file  3: Figure S3A–B, arrows), or 
whether this was related specifically to disruptions in the 
facial motor nucleus, we conditionally removed Shox2 in 
all neural crest derivatives using a Wnt1-Cre driver. This 
resulted in the complete loss of Shox2 expression in the 
face (Additional file 5: Figure S4A, B), and ultimately did 
not appear to result in any disruptions to the develop-
ment of the facial (VII) nerves (Additional file 5: Figure 
S4C, D). Together these results show impaired axonal 
projection properties of visceral motor neurons (vMNs) 
in the facial motor nucleus of the hindbrain in mice lack-
ing Shox2.
Loss of Shox2 in the facial motor nucleus results in elevated 
apoptosis
Since Shox2-mutant embryos and neonates display 
impaired axonal projection properties and were unable 
to nurse properly, we next wanted to determine if devel-
opment of the facial motor nucleus was disrupted in the 
absence of Shox2. Both neurofilament and lacZ staining 
of P0 control and Nestin-Cre; Shox2flox/− or Nestin-Cre; 
Shox2lacZ/flox pup brains demonstrated that the facial 
motor nucleus was severely reduced in size, with dis-
ruptions in neuronal spatial organization in mice lack-
ing Shox2 function (Figure  4a–f, arrows; note that the 
Shox2lacZ allele is a null or severely hypomorphic allele, 
see “Methods”). While the symmetry between the left 
and right facial motor nuclei appears to be relatively 
maintained (Figure 4c–d, arrows), the two lobes that nor-
mally comprise the facial motor nucleus are no longer 
present (Figure  4e–f, arrows). We next investigated 
whether an increase in apoptosis could account for the 
changes observed in the facial motor nucleus of Shox2-
mutant brains. We found an increase in the number of 
apoptotic cells present at E12.5 and E14.5 in the facial 
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Figure 2 Facial nerve truncations in Shox2-mutant animals. a–d Side view of the E11.5 (a, b) or E11.75 (c, d) face of control (a, c), Nestin-Cre; 
Shox2flox/− (b) and Shox2−/− (d) embryos stained with the 2H3 anti-neurofilament antibody. At E11.5 the main branch of the facial nerve (VII) begins 
to separate into smaller projections in control embryos (a, arrows), while a single branch is visible in Nestin-Cre; Shox2flox/− conditional knockout 
embryos (compare a to b, arrows). At E11.75 the facial nerve is noticeably truncated in the Shox2−/− embryos (compare c to d, arrows), while the 
trigeminal nerve (V; a–d, arrowheads) remains intact. e–h Side view of the E12.5 face of control (e) and Nestin-Cre; Shox2flox/− (f–h) embryos stained 
with the 2H3 antibody display the range in severity of facial nerve truncation, with f being the least severe truncation and h being the most severe 
truncation observed in Nestin-Cre; Shox2flox/− embryos (compare e to f–h, dashed-box). (i–n) Side view of the E13.5 (i, j), E14.5 (k, l) and P0 (m, n) 
face of control (i, k, m) and Nestin-Cre; Shox2flox/− (j, l, n) animals stained with the 2H3 antibody. At E13.5 and E14.5 the zygomatic (z), superior buc-
colabial (sbl), inferior buccolabial (ibl) and marginal mandibular (mm) nerve branches can be seen in control (i, k) embryos but are not visible in 
Nestin-Cre; Shox2flox/− (j, l) embryos (compare i to j and k to l, arrows). At P0 the truncated remnants of what appears to be the superior buccolabial 
nerve were observable in Nestin-Cre; Shox2flox/− pups (compare m to n, arrows). ey eye, b buccal nerve, sm superficial masseter nerve. Scale bar 
500 μm.
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motor nucleus of Shox2-mutants (Figure 4g–l); however, 
no significant increase in apoptosis was detected in the 
E16.5 or P0 facial motor nucleus of Shox2-mutant ani-
mals (Figure 4m–r). We observed a ~7.5-fold increase in 
the number of cleaved active-CASP3 + cells in the E12.5 
facial motor nucleus of Nestin-Cre; Shox2flox/− animals as 
compared to controls (Figure  4i; control n =  3, Nestin-
Cre; Shox2flox/− n =  3, p =  0.0038). We also observed a 
striking ~17.7-fold increase in the number of cleaved 
active-CASP3 + cells in the E14.5 facial motor nucleus of 
Figure 3 LacZ staining highlights truncated facial nerves and impaired axonal projection properties of vMNs in mice lacking Shox2 function. a–j 
BAC RP23-105B3-lacZ transgenic animals stained with X-gal. a, b Side view of the E11.5 face of control (a) and Nestin-Cre; Shox2flox/− (b) embryos 
display similar axonal projections of the main branch of the facial nerve (VII) (compare a to b, arrows). c, d Side view of the E12.5 face of control (c) 
and Nestin-Cre; Shox2flox/− (d) embryos display facial nerve truncation in mice lacking Shox2 function (compare c to d, arrow). e–h Side view of the 
E13.5 (e, f) and E14.5 (g, h) face of control (e, g) and Nestin-Cre; Shox2flox/− (f, h) embryos highlights the zygomatic (z), temporal (t), superior buccola-
bial (sbl), inferior buccolabial (ibl) and marginal mandibular (mm) nerve branches in control (e, g) embryos, which are truncated or lost in Nestin-Cre; 
Shox2flox/− embryos (compare e to f and g to h, arrows). i, j Side view of the P0 face of control (i) and Nestin-Cre; Shox2flox/− (j) pups demonstrate 
that the facial nerves are absent in Nestin-Cre; Shox2flox/− pups (compare i to j, arrows). ey eye, b buccal nerve, sm superficial masseter nerve. Scale 
bar 500 μm.
(see figure on next page.)
Figure 4 Nestin-Cre driven conditional Shox2-deletion results in disruptions in the facial motor nucleus and changes in cell death. a, b Ventral view 
of the P0 brain of control (a) and Nestin-Cre; Shox2flox/− (b) animals stained with the 2H3 antibody demonstrate that the facial motor nucleus (nVII) is 
severely reduced in Nestin-Cre; Shox2flox/− pups (compare a to b, dashed-circle and arrows). c–f X-gal staining of P0 control (c, e) and Nestin-Cre;  
Shox2lacZ/flox (d, f) pup brains (viewed ventrally) show Shox2 expression in the facial motor nucleus and demonstrate that the nucleus is severely 
reduced in size (compare e to f, arrows) in mice lacking Shox2 function. Cleaved active-CASP3 immunostaining on E12.5 (g, h), E14.5 (j, k), E16.5 (m, 
n) and P0 (p, q) control (g, j, m, p) and Nestin-Cre; Shox2flox/− mutant (h, k, n, q) sagittal sections through the facial motor nucleus (nVII). i Quantifica-
tion of the number of cleaved active-CASP3 + cells present in the E12.5 facial motor nucleus (see g, h) of control and Nestin-Cre; Shox2flox/− embryos 
(plotted values are the mean ± S.E.M, 3 sections per animals, n = 3 animals, p = 0.0038). l Quantification of the number of cleaved active-
CASP3 + cells present in the E14.5 facial motor nucleus (see j, k) of control and Nestin-Cre; Shox2flox/− embryos (plotted values are the mean ± S.E.M, 
3 sections per animals, n = 3 animals, p = 0.0007). o Quantification of the number of cleaved active-CASP3 + cells present in the E16.5 facial 
motor nucleus (see m, n) of control and Nestin-Cre; Shox2flox/− embryos (plotted values are the mean ± S.E.M, 3 sections per animals, n = 3 animals, 
p = 0.1929). r Quantification of the number of cleaved active-CASP3 + cells present in the P0 facial motor nucleus (see p, q, dashed-circle) of control 
and Nestin-Cre; Shox2flox/− embryos (plotted values are the mean ± S.E.M, 3 sections per animals, n = 3 animals, p = 0.6875). s Quantification of 
the number of cleaved active-CASP3 + cells present in and around the P0 facial motor nucleus (see p, q, entire panel including cells within the 
dashed-circle) of control and Nestin-Cre; Shox2flox/− embryos (plotted values are the mean ± S.E.M, 3 sections per animals, n = 3 animals, p = 0.0007). 
t, u Representative binary particle area diagrams from ImageJ displaying Shox2lacZ + cell staining at E14.5 (t) and P0 (u) in controls and NestinCre; 
Shox2lacZ/flox facial motor nuclei. v Quantification of the area of Shox2lacZ + cells present in sagittal sections through the center of the E14.5 facial 
motor nucleus (see t) of control and Nestin-Cre; Shox2lacZ/flox embryos (plotted values are the mean ± S.E.M, control = 3, Nestin-Cre; Shox2lacZ/flox = 3, 
p = 0.0027). w Quantification of the area of Shox2lacZ + cells present in sagittal sections through the center of the P0 facial motor nucleus (see u) of 
control and Nestin-Cre; Shox2lacZ/flox animals (plotted values are the mean ± S.E.M, control = 3, Nestin-Cre; Shox2lacZ/flox = 3, p = 0.0011). cb cerebel-
lum. a–f Scale bar 500 μm. g–q Scale bar 250 μm.
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Nestin-Cre; Shox2flox/− animals as compared to controls 
(Figure  4l; control n =  3, Nestin-Cre; Shox2flox/− n =  3, 
p  =  0.0007). While the slight elevation in apoptosis 
detected in the E16.5 and P0 facial motor nucleus of 
Shox2-mutant animals was not significantly different 
from controls (Figure  4o, r), we did observe a ~3.5-fold 
increase in the number of cleaved active-CASP3 + cells 
at P0 when we included the tissue immediately surround-
ing the facial motor nucleus of Nestin-Cre; Shox2flox/− 
animals (Figure 4p–q, entire panel including cells within 
the dashed-circle) in our cell count (Figure  4s; control 
n = 3, Nestin-Cre; Shox2flox/− n = 3, p = 0.0007). Moreo-
ver, when we calculated the area of Shox2lacZ  +  cells 
remaining in sagittal sections through the center of the 
facial motor nucleus of Nestin-Cre; Shox2lacZ/flox animals 
as compared to controls at E14.5 (Figure 4t) and P0 (Fig-
ure 4u), we observed a ~44% decrease in the area of Shox-
2lacZ + cells in the E14.5 facial motor nucleus (Figure 4v; 
control n = 3, Nestin-Cre; Shox2lacZ/flox n = 3, p = 0.0027) 
and a ~53% decrease in the area of Shox2lacZ + cells in 
the P0 facial motor nucleus (Figure  4w; control n  =  3, 
Nestin-Cre; Shox2lacZ/flox n  =  3, p  =  0.0011). There-
fore, the higher levels of apoptosis are correlated with a 
decrease in the size of the facial motor nucleus, and taken 
together, the results demonstrate that apoptosis con-
tributes to the disruptions observed in the facial motor 
nucleus of Nestin-Cre; Shox2flox/− animals.
Shox2 is required for normal expression of markers of vMN 
identity in the facial motor nucleus
Given the marked reduction in size of the facial motor 
nucleus in Shox2 mutants (Figure  4), we next sought to 
investigate whether factors other than facial (VII) nerve 
truncation and cell death could be changing in the facial 
motor nucleus following the loss of Shox2. Prior to E14.5, 
we did not observe any obvious changes in gene expres-
sion or disruptions to the migratory patterns of vMNs 
(Additional file  2: Figure S2F-K, M-R). At E14.5, how-
ever, sagittal sections of the facial motor nucleus showed 
reductions in the overall size of the nucleus in Nestin-Cre; 
Shox2lacZ/flox embryos (Figure  5b), which was consist-
ent with the regional increase in the number of cleaved 
active-CASP3 + cells at this time-point (Figure 4k). Since 
SHOX2 has been previously shown to regulate Isl1 [34], 
an important regulator of vMN development [7, 19, 22], 
we next examined the expression of Isl1 in Shox2-mutant 
animals. We observed a regionally restricted loss of Isl1 
and the hindbrain vMN determinant Phox2b in the facial 
motor nucleus as early as E14.5 in Nestin-Cre; Shox2flox/− 
mutant embryos as compared to controls (Figure  5e–h, 
arrows). Since loss of Isl1 function in the trigeminal and 
DRG have been shown to result in changes in the expres-
sion of contactin 2 (Cntn2), tubulin β-3 chain (Tubb3) 
and peripherin 1 (Periph) [38], and given that Phox2b-
deficient mice have been used to identify the facial motor 
nucleus as a source of Slit homolog 2 (Slit2) signaling 
[39], we next examined the expression patterns of these 
genes. Although subtle changes in the spatial patterns 
and expression levels of Cntn2 and Tubb3 were observed, 
Periph1, solute carrier family 18 (Slc18a3) and Slit2 
phenocopied the regionally specific absence of Isl1 and 
Phox2b in the facial motor nucleus at E14.5 in Nestin-Cre; 
Shox2flox/− mutant embryos (Figure  6i–r, dashed-circle 
and arrows). The changes in expression for these genes 
continued to be observed between Nestin-Cre; Shox2flox/− 
mutant embryos and controls at E16.5 (data not shown). 
Together, these results show that Shox2 is required for 
normal expression of markers of vMN identity at E14.5.
Loss of Shox2 results in severe developmental disruptions 
to the facial motor nucleus
In contrast to the subtle changes at E14.5, postnatally 
we observed a drastic reduction in the size of the facial 
motor nucleus and changes to the overall organization of 
motor neurons in Nestin-Cre; Shox2flox/− mutant animals 
(Figure  6), consistent with the phenotype displayed in 
Figure 4. Specifically, lacZ staining of P0 control and Nes-
tin-Cre; Shox2lacZ/flox sagittal sections of the facial motor 
nucleus demonstrate that the nucleus is reduced in size 
in mice lacking Shox2 (Figure 6b). The expression levels 
of Isl1, Phox2b, Cntn2, Tubb3, Periph, Slc18a3 and Slit2 
were all strikingly reduced in the P0 facial motor nucleus 
of Nestin-Cre; Shox2flox/− mutant animals as compared to 
controls (Figure  6e–r, dashed-circle). Since conditional 
inactivation of Shox2 in the brain was previously shown 
to result in the down-regulation of Shh expression in dor-
sal-residing Purkinje cells of the cerebellum [33], we next 
investigated whether loss of Shox2 function in the facial 
motor nucleus interfered with the expression of Shh. The 
expression of both Shh and patched 1 (Ptch1) were absent 
in the facial motor nucleus of Nestin-Cre; Shox2flox/− 
mutant animals (Figure 6s–v).
Although the loss of Shox2 in the brain resulted in dras-
tic reductions in the size of the facial motor nucleus and 
the expression of the above-mentioned genes, the spared 
vMNs remaining in the facial motor nucleus of Shox2 
mutants appeared to be mostly localized to the dorsal 
regions of the nucleus (Figure  6B″, f, n). This suggested 
that there could be a region-specific loss of distinct sub-
nuclei in the facial motor nucleus in Shox2-mutant ani-
mals. Therefore we examined the expression patterns 
of these same genes in coronal sections of the facial 
motor nucleus, as this would allow us to more clearly 
observe the six subnuclei that comprise the main facial 
motor nucleus; specifically the lateral, dorsolateral, dor-
sal intermediate, ventral intermediate, dorsomedial and 
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ventromedial nuclei [23, 24]. LacZ staining of P0 con-
trol and Nestin-Cre; Shox2lacZ/flox coronal sections of the 
facial motor nucleus demonstrated that elimination of 
Shox2 resulted in the loss of medially-localized subnuclei, 
specifically the dorsomedial and ventromedial nuclei, 
in addition to severe disruptions to the development of 
the intermediate nuclei, especially the dorsal interme-
diate (Figure  7b). Similar to what we observed at P0 in 
sagittal sections of the facial motor nucleus (Figure  6), 
the expression of Isl1, Phox2b, Cntn2, Tubb3, Periph, 
Slc18a3, Slit2, Shh and Ptch1 were restricted to the lat-
eral or intermediate regions in coronal sections of the 
facial motor nucleus, or completely lost in Nestin-Cre; 
Shox2flox/− mutant animals as compared to controls (Fig-
ure  7e–v, dashed-circle). While the regional changes in 
expression were variable between the genes examined, in 
general the dorsomedial, ventromedial and dorsal inter-
mediate subnuclei of the facial motor nucleus appeared 
to be most strongly affected in Shox2-mutant animals 
(Figure 7), which may reflect a regional specific require-
ment for Shox2 in the facial motor nucleus or may indi-
cate that there are populations of vMNs within the facial 
motor nucleus that do not express Shox2 during develop-
ment. Together, the results suggest that Shox2 is required 
for the development of specific subcompartments within 
the broader facial motor nucleus.
Discussion
In this study, we used a Nestin-Cre driver and a condi-
tional knockout strategy to determine the contribution of 
Shox2 to the development of the facial motor nucleus. We 
found that mice lacking Shox2 function failed to develop 
Figure 5 Loss of Shox2 in the brain results in subtle changes in the expression pattern of Isl1 and Phox2b in the E14.5 facial motor nucleus. a 
Diagram of a sagittal section through the E14.5 brain highlights the regions represented in b–r. b X-gal stained sagittal sections through E14.5 
embryos shows decreased staining in the facial motor nucleus (nVII) of Nestin-Cre; Shox2lacZ/flox (B″) embryos that lack Shox2 function, as compared 
to controls (B′). c–r ISH on E14.5 control (c, e, g, i, k, m, o, q) and Nestin-Cre; Shox2flox/− (d, f, h, j, l, n, p, r) sagittal sections shows loss of Shox2 expres-
sion (compare c to d, dashed-circle), and subtle changes in the spatial expression patterns of Isl1 (compare e to f, arrow), Phox2b (compare g to h, 
arrow), Cntn2 (compare i to j, dashed-circle), Tubb3 (compare k to l, dashed-circle), Periph (compare m to n, arrow), Slc18a3 (compare o to p, arrow) 
and Slit2 (compare q to r, arrow) in the developing facial motor nucleus. The dashed-circles in paired panels being compared (e.g. B′ and B″) are the 
same size, and this applies from B′ to r. Scale bar 250 μm.
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proper vMNs in the medial subnuclei normally present 
in the facial motor nucleus, which was accompanied by 
truncated or absent facial (VII) nerve projections. Our 
results have uncovered an unexpected and novel role for 
Shox2 in the development of the facial motor nucleus and 
facial (VII) nerves. Specifically, Shox2 is required for cell 
survival and perhaps plays a region-specific role in the 
development and/or maintenance of normal transcrip-
tional programs of vMNs of the facial motor nucleus. 
Ultimately, in the absence of Shox2, pups lack facial (VII) 
nerves and display abnormal feeding behavior.
Shox2 is required for cell survival in the facial motor 
nucleus
Nestin-Cre-mediated deletion of Shox2 in the brain 
resulted in a significant increase in the number of 
apoptotic cells present at E12.5 and E14.5 in the facial 
motor nucleus of Shox2-mutants. Given that truncated 
and abnormal facial (VII) nerve projections could be 
observed in Nestin-Cre; Shox2flox/− mutants from E11.5 
onward, apoptosis could: (1) contribute to the disrup-
tions in the axonal projection properties of vMNs in 
the facial motor nucleus, or (2) result from a lack of 
Figure 6 Shox2 is required for the proper development of the facial motor nucleus. a Diagram of a sagittal section through the P0 brain highlights 
the regions represented in b–v. b X-gal stained sagittal sections through P0 brains show a decrease in staining levels in the facial motor nucleus 
(nVII) of Nestin-Cre; Shox2lacZ/flox (B″) animals as compared to controls (B′). c–v ISH on P0 control (c, e, g, i, k, m, o, q, s, u) and Nestin-Cre; Shox2flox/− (d, 
f, h, j, l, n, p, r, t, v) sagittal sections shows loss of Shox2 expression (compare c to d, dashed-circle), and decreases in Isl1 (compare e to f, dashed-
circle), Phox2b (compare g to h, dashed-circle), Cntn2 (compare i to j, dashed-circle), Tubb3 (compare k to l, dashed-circle), Periph (compare m to n, 
dashed-circle), Slc18a3 (compare o to p, dashed-circle), Slit2 (compare q to r, dashed-circle), Shh (compare s to t, dashed-circle) and Ptch1 (compare u 
to v, dashed-circle) expression in the facial motor nucleus. nV trigeminal nucleus, RTN retrotrapezoid nucleus. Scale bar 250 μm.
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peripheral trophic support for the facial (VII) nerves in 
Shox2 mutants. Similarly, the changes observed in the 
size of the P0 facial motor nucleus also likely results 
from elevated cell death embryonically in Shox2-mutant 
animals. However, given that there are ~6,400 neurons 
that comprise the facial motor nucleus [23, 24], future 
analysis is needed to quantify cell death accurately over 
a developmental time course to determine if the levels of 
cell death we observe in Shox2-mutant animals is suffi-
cient to account for the disruptions observed in the facial 
motor nucleus in the absence of Shox2. This is similar to 
what has been documented in Isl1 mutants, as loss of Isl1 
is associated with increased cell death in the trigeminal, 
DRG, hindbrain and neural tube prior to E14.5, while 
Figure 7 Loss of Shox2 function in the facial motor nucleus interferes with the proper development of the medial subnuclei. a Diagram of a 
coronal section through the P0 brain highlights the region represented in panels b–v, particularly the 7 neuronal clusters that form the facial motor 
nucleus (nVII, dashed-circle) (image adapted from [23]). b X-gal stained coronal sections through P0 brains shows a loss of medial neuronal clusters 
in the facial motor nucleus of Nestin-Cre; Shox2lacZ/flox (B″) brains as compared to controls (B′). c–v ISH on P0 control (c, e, g, i, k, m, o, q, s, u) and 
Nestin-Cre; Shox2flox/− (d, f, h, j, l, n, p, r, t, v) coronal sections shows loss of Shox2 expression (compare c to d, dashed-circle), and decreases in Isl1 
(compare e to f, dashed-circle), Phox2b (compare g to h, dashed-circle), Cntn2 (compare i to j, dashed-circle), Tubb3 (compare k to l, dashed-circle), 
Periph (compare m to n, dashed-circle), Slc18a3 (compare o to p, dashed-circle), Slit2 (compare q to r, dashed-circle), Shh (compare s to t, dashed-
circle) and Ptch1 (compare u to v, dashed-circle) expression in the facial motor nucleus. DA dorsal accessory, DM dorsomedial, VM ventromedial, DI 
dorsal intermediate, VI ventral intermediate, DL dorsolateral, Lat lateral. Scale bar 250 μm.
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later developmentally Isl1 functions during subtype spec-
ification [19, 21, 22, 38]. Accordingly, if Shox2 is required 
to maintain proper Isl1 expression in vMNs of the facial 
motor nucleus, similar to what has been observed dur-
ing heart development [34], and Isl1 is required to induce 
the subsequent differentiation of adjacent neurons, simi-
lar to what has been observed in the neural tube [19], 
this could explain the elevated cell death observed in 
neurons adjacent to the facial motor nucleus at P0. Pat-
tyn et al. [7] have shown that unlike PHOX2B and ISL1, 
NKX6 proteins (NKX6.1 and NKX6.2) are not required 
for the establishment of vMN identity, yet NKX6 proteins 
are necessary to prevent vMNs from trans-differentiat-
ing into improper neuronal subtypes. Similar to Shox2 
mutants, mice lacking Nkx6 function display impaired 
axonal projection properties of vMNs and facial nerve 
disruptions [7]. Together, the Shox2-mutant model could 
provide an additional example to support the argument 
of Pattyn et  al. that vMN differentiation requires multi-
ple inputs rather than one dominant determinant [7]. 
Alternatively, necrosis in the facial motor nucleus region 
could be responsible for the observed ectopic increase in 
the number of apoptotic cells in tissue immediately sur-
rounding the facial motor nucleus.
Shox2 may play a regional specific role in the 
transcriptional programs of vMNs during development 
of the facial motor nucleus
In this study we have shown that Shox2 is expressed in 
the facial motor nucleus and provide evidence that Shox2 
plays an important role during facial motor nucleus 
development. We have demonstrated that loss of Shox2 
function results in the down-regulation or loss of Isl1, 
Phox2b, Cntn2, Tubb3, Periph, Slc18a3 and Slit2 in 
the facial motor nucleus. Since loss of Isl1 function in 
the trigeminal and DRG have been shown to result in 
changes in the expression of Cntn2, Tubb3 and Periph 
[38], and given that Phox2b-deficiency influences Slit2 
expression [39], we propose that the observed changes 
in gene expression in Shox2 mutants could result from 
direct or indirect regulation of Isl1 and/or Phox2b by 
SHOX2. Since Isl1 can rescue Shox2-mediated bradycar-
dia, and Isl1 has been shown to be a transcriptional tar-
get of SHOX2 in vitro [34], it would not be surprising if 
SHOX2 regulates Isl1 in the facial motor nucleus.
As conditional inactivation of Shox2 in the brain was 
previously shown to result in the down-regulation of Shh 
expression in dorsal-residing Purkinje cells of the cerebel-
lum [33], we also investigated whether loss of Shox2 func-
tion in the facial motor nucleus interfered with expression 
of Shh. Similar to what was observed in the cerebellum, 
the expression of both Shh and Ptch1 were reduced or 
lost in the facial motor nucleus of Shox2-mutant animals, 
suggesting that Shox2 acts upstream of SHH signaling, or 
that the neurons that would normally express Shh under-
went apoptosis earlier embryonically in Shox2-mutant 
animals. Despite the known critical function of Shh in 
motor neuron generation [7, 11–15], the role of Shh in 
the later development of the vMNs of the facial motor 
nucleus remains largely unknown. In rats, SHH appears to 
play a role in the regeneration of the facial motor nucleus 
and facial (VII) nerves following nerve injury [16]. There-
fore, as the facial motor nucleus normally undergoes mas-
sive cell death from E19 to P10 [24], the late-onset of Shh 
expression in the facial motor nucleus could be localized 
to specific vMNs for cell survival. This hypothesis will be 
tested in future studies. Together, it appears that Shox2 is 
necessary for proper Isl1 and Phox2b expression levels in 
the developing facial motor nucleus, and is subsequently 
required for late-onset Shh expression; whether this 
results from facial (VII) nerve disruption and embryonic 
apoptosis in Shox2 mutants or occurs via direct or indi-
rect regulation of Isl1, Phox2b and/or Shh has yet to be 
determined.
Since the phenotype observed in the facial motor 
nucleus of Shox2 mutants, including the changes in gene 
expression, were most prominent in the medial and 
intermediate subnuclei, factors other than SHOX2 must 
contribute to the development and survival of the lat-
eral subnuclei of the facial motor nucleus. The observed 
phenotype could reflect a regional specific requirement 
for Shox2 in the facial motor nucleus or indicate that 
there are populations of vMNs within the facial motor 
nucleus that do not express Shox2. The latter hypothesis 
is supported by results depicted in Figure S2F, H, J, as the 
Shox2 expression domain appears more restricted then 
those of Isl1 and Phox2b; therefore, future analysis will 
be required to examine whether SHOX2−/ISL1+ and/or 
SHOX2−/PHOX2B+ cell populations exist in the facial 
motor nucleus. Alternatively, if vMNs destined for the 
lateral subnuclei of the facial motor nucleus are specified 
first, this could explain why they are the least disrupted 
group of nuclei apparent in Shox2 mutants. However, 
considering the severe disruptions to facial (VII) nerve 
development observed in Shox2 mutants, including those 
that innervate the nasolabial musculature that are sup-
plied by neurons located in the lateral subnuclei of the 
facial motor nucleus [23, 24], it is also possible that Shox2 
is required for the proper development of the lateral 
facial motor nuclei. This is further supported by changes 
in the expression of Cntn2, Tubb3, Shh and Ptch1 in the 
lateral facial motor nucleus. Taken together, it appears 
that Shox2 may play a role in the transcriptional pro-
grams of vMNs during development of the facial motor 
nucleus; whether this occurs via a regional requirement 
for Shox2 in the facial motor nucleus or influences the 
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development of the entire facial motor nucleus in an 
equal manner has yet to be determined.
Disruptions in the development of the facial motor nucleus 
influences the axonal projections of vMNs of the facial (VII) 
nerves in Shox2‑mutant animals
As Shox2-mutant neonates display impaired feeding 
behavior, we wondered if this was due to a loss of a sub-
set of axons in the nerves present in the face or whether 
it reflected a more substantial innervation deficit. Our 
findings demonstrate that the loss of Shox2 causes severe 
truncations and disruptions to the development of the 
facial (VII) nerves, which could result from: (1) a lack 
of peripheral trophic support for the facial (VII) nerves, 
(2) vMN cell death, (3) facial motor nucleus defects that 
influence the axonal projections of vMNs and target 
acquisition of the facial (VII) nerves, or a combination 
thereof. It should be mentioned, however, that disrup-
tions in peripheral trophic support for the facial (VII) 
nerves would have to result from Shox2’s autonomous 
function in the facial (VII) nerves themselves, and not 
as a result of Shox2 playing a role as a peripheral target, 
since loss of Shox2 expression in the face in Wnt1-Cre; 
Shox2flox/− mutant animals does not disrupt facial (VII) 
nerve development.
Given that the face of Shox2-mutant neonates are 
severely devoid of innervation, the behavioral abnormali-
ties exhibited by Shox2-mutant animals could be attrib-
uted to facial paralysis. Disruption of Hoxb1 function 
has been shown to result in facial nerve defects in mice, 
where the phenotype is similar to that of human patients 
with Bell’s Palsy or Moebius Syndrome [40]. Similarly, 
other Hox-mutant mouse models have displayed disrup-
tions in facial (VII) nerve development, which correlate 
with facial impairments [36]. Moreover, Isl1 mutants dis-
play disruptions in the development of the facial (VII) 
nerves, however similar to Shox2 mutants, early postna-
tal lethality has limited the behavioral analysis of these 
animals [21, 22, 38]. To determine if disruption to the 
facial motor nucleus is the cause of the early postnatal 
lethality of Nestin-Cre; Shox2flox/− animals, future stud-
ies could employ more restricted hindbrain Cre lines 
to specifically remove Shox2 expression from the facial 
motor nucleus. If regionally restricted loss of Shox2 in 
facial motor nucleus does not result in postnatal lethal-
ity, future studies could examine Shox2-mutant behavior 
later postnatally and in the adult to test whether Shox2-
mutant animals have control over their face or are experi-
encing facial paralysis.
Conclusions
Taken together, these results demonstrate that elimina-
tion of Shox2 in the brain results in disruptions in the 
development of the facial (VII) nerves and the facial 
motor nucleus. The present study demonstrates that 
in the absence of Shox2 the murine face develops with 
severe innervation deficits, ultimately highlighting the 
importance of Shox2 to proper facial motor nucleus 
development. The Shox2-mutant model can now be 
exploited to further our understanding of normal neu-
ronal development and circuit formation; processes 




To generate conditional Shox2 knockout animals, mice 
bearing the Nestin-Cre transgene [35], in addition to a 
wild-type and deleted Shox2 allele, were crossed to mice 
carrying two floxed Shox2 alleles [25]. Shox2 mutants 
were positive for Nestin-Cre and carried one deleted 
and one floxed Shox2 allele. Littermate control animals 
carried either one or two functional copies of Shox2, as 
no changes in the gross morphology of the facial motor 
nucleus or facial nerves were observed in heterozygotes. 
We designated embryonic day 0.5 (E0.5) to be noon on 
the day a plug was detected. Mice were maintained on a 
mixed C57BL/6-129/Sv background. Mice carrying the 
deleted and floxed Shox2 alleles were described previ-
ously [25], while mice carrying the Nestin-Cre transgene 
were from the Jackson Laboratory (Bar Harbor, ME), 
and described previously [35]. BAC RP23-105B3-lacZ 
transgenic animals were described previously [37], while 
Shox2lacZ mice are described below. All experiments per-
formed at the University of Calgary were approved by the 
Life and Environmental Sciences Animal Care Commit-
tee. Experiments were conducted on three embryos or 
neonates of a particular genotype at each gestational and 
postnatal time point described, unless otherwise stated.
Generation and characterization of Shox2lacZ mice
Shox2lacZ mice were produced by pronuclear injection of 
a 15.4 kb NarI fragment (Additional file 1: Figure S1A) of 
BAC RP23-103D17-lacZ that has a lacZ cassette inserted 
in the Shox2 gene as previously described [37]. One of 
seven transgenic lines carrying this transgene showed an 
unexpected expression pattern that recapitulated all of 
the expression domains of the endogenous Shox2 gene 
(compare Additional file  1: Figure S1D–S1E), despite 
evidence that the regulatory regions controlling expres-
sion in most of these domains is not within the transgene 
sequence [37]. This result suggested that the transgene 
in this line, designated Shox2lacZ may have inserted into 
the Shox2 locus. Although rare, targeting of transgenic 
constructs generated by pronuclear injection has been 
reported [41, 42]. We confirmed a loss of Shox2 function 
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by a complementation test and targeting was shown 
by long range PCR (Additional file  1: Figure S1B). For 
the former, the Shox2lacZ allele was combined with the 
Shox2− allele. Mice with the genotype Shox2lacZ/− died at 
birth with defects similar to Shox2 null animals, showing 
non-complementation (the limb and palate phenotypes 
are shown in Additional file  1: Figure S1F–K, respec-
tively). Long-range PCR was performed with a forward 
primer corresponding to a sequence 4.5 kb upstream of 
Shox2 (327 bp upstream of the 5′ limit of the transgene) 
and a reverse primer within the lacZ sequence. These 
primers amplified a 5.2  kb PCR product from DNA of 
Shox2lacZ mice as expected if the transgene were inserted 
at the Shox2 genomic locus (Additional file  1: Figure 
S1B). Furthermore, western blotting failed to detect 
SHOX2 protein in lysates from E11.5 limb buds of Shox-
2lacz/lacZ embryos while lysates from wild-type littermate 
embryos showed clear SHOX2 signal (data not shown). 
Therefore we conclude that the Shox2lacZ allele is a null 
or severely hypomorphic allele. The precise molecular 
nature of the transgene insertion at its 3′ end has not yet 
been determined.
X‑gal staining
Embryos with lacZ transgenes were stained with X-gal 
according to standard techniques [43]. ImageJ was used 
to determine the relative size of the facial motor nucleus 
in lacZ stained control and NestinCre; Shox2lacZ/flox sagit-
tal sections at E14.5 and P0 (Figure 4t–u).
In situ hybridization
Whole-mount in situ hybridization (WISH) with a ribo-
probe was previously described [44]. In situ hybridiza-
tion (ISH) on cryosections was previously described [25]. 
The Shox2 [43], Shh [45] riboprobes have been described 
elsewhere. PCR primers used for generating the Ptch1 
riboprobe are as follows: Fwd: GGGAGGAAATGCT-
GAATAAAGCC and Rev: CCAGGAGGAAGACAT-
CATCCACAC, while the primers used for generating 
the Isl1, Cntn2, Tubb3, Periph, Slc18a3, Phox2b, and Slit2 
riboprobes were obtained from the Allen brain atlas 
website (http://www.brain-map.org). DIG labeled ribo-
probes were detected with an AP-conjugated anti-DIG 
antibody (Roche) and BM Purple AP (Roche) was used 
as the color development substrate. All samples/slides 
used for comparisons were processed together. Following 
staining, tissue sections were mounted using Aqua Poly/
Mount (Polysciences Inc.). ISH images were taken with 
a Leica MZ12.5 stereomicroscope using the associated 
Leica software. Brightness and/or contrast of the entire 
image was adjusted using Adobe Photoshop CS5.1 if 
deemed appropriate.
Immunohistochemistry
Dissected embryos and postnatal brains were placed in 
ice-cold PBS, and fixed in 4% paraformaldehyde (PFA) 
overnight at 4°C. The tissue was washed in PBS and equili-
brated in 30% sucrose/PBS overnight at 4°C. Both embryos 
and postnatal brains were embedded in Tissue Freezing 
Medium (TFM, Triangle Biomedical Sciences) and cryo-
sectioned (16–20  μm sections). For immunohistochem-
istry (IHC), cryosections were rehydrated in PBS, washed 
with PBT (0.1% Triton-X), blocked using 5% normal goat 
serum (NGS) for 2  h at room temperature, and exposed 
to anti-active Caspase-3 (1:400, BD Pharmingen or 1:500, 
Promega) at 4°C overnight. Slides were then washed with 
PBT and exposed to secondary antibody (1:200, alexa 488 
goat-anti-rabbit, Life Technologies) for 2 h at room tem-
perature. Sections were mounted using Aqua Poly/Mount 
(Polysciences Inc.). Fluorescent IHC images were captured 
on a Zeiss LSM710 confocal microscope.
Neurofilament staining
Antibodies recognizing neurofilaments (2H3) were used 
to visualize nerves in embryos or postnatal day 0 (P0) 
pup heads (skin was removed at P0). Samples were fixed 
at least 4  h in Dent’s fixative (4:1, Methanol:DMSO). 
Embryos and P0 heads were processed according to 
standard techniques previously described [26]. The 2H3 
antibody was developed by T. Jessell/J. Dodd [46] and 
was obtained from the Developmental Studies Hybri-
doma Bank developed under the auspices of the NICHD 
and maintained by The University of Iowa, Department 
of Biology, Iowa City, IA 52242.
Quantification methods and statistical analysis
Quantitative results for cell counts are represented by 
mean scores ±  S.E.M. and were analyzed by two-tailed 
unpaired t tests using Prism 3 for Macintosh (GraphPad 
Software, La Jolla, CA, USA).
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Additional files
Additional file 1: Figure S1. Shox2lacZ transgenic analysis. (A) Schematic 
of the 15.4 kb Shox2-LacZ transgene (above) and the endogenous Shox2 
genomic locus (below). The five exons are shown as vertical boxes; red 
indicates the coding portion of the exons and unfilled regions indicate the 
untranslated regions (UTRs). Green boxes/arrows indicate the sequences 
and sizes (in basepairs) amplified by PCR in panels B and C. The 5,200 bp 
PCR product amplified from genomic DNA of Shox2lacZ mice (panel B) 
provides evidence for targeting via homologous recombination at the 5′ 
end of the gene (dotted lines). The forward primer for this PCR is 327 bp 
upstream of the transgene sequence and the reverse primer is within 
the lacZ cassette (blue). The 3′ insertion site has not yet been character-
ized. (B) Long range PCR demonstrating location of the transgene at the 
Shox2 locus, as shown by the 5.2 kb PCR product in five mice carrying the 
transgene but not in wild-type controls. (C) Genotyping of Shox2lacZ mice. 
The wild-type allele is indicated by the 705 bp band and the transgene 
insertion is detected by the 392 band, with both bands amplified in 
heterozygote animals. The two lanes at right have only the lower band, 
indicating that homozygous Shox2lacz/lacZ mice do not have an intact exon 
1 in their genomes, which further supports targeting at the Shox2 locus. 
(D) WISH for Shox2 at E12.5. (D’-D’’’) ISH for Shox2 on E12.5 brain sections. 
(E) X-gal staining of an E12.5 Shox2lacZ/+ embryo and corresponding brain 
sections (E’-E’’’). D’ and E’ are located anterior to D’’’ and E’’’. (F-I) Forelimb 
(F, G) and hindlimb (H, I) skeletons of newborn Shox2lacZ/− mice (G, I) and 
controls (F, H) showing reduction in the humerus (h) and femur (f ) as 
those found in Shox2-null mice. (J, K) Hematoxylin and eosin (H&E) stained 
coronal sections through the palate of newborn Shox2lacZ/− mice (K) 
and controls (J) displays a cleft palate (compare J to K, dashed-box and 
arrow) similar to what is found in Shox2-null mice. Abbreviations: ey, eye; 
tg, trigeminal; di, diencephalon; mes, mesencephalon; hb, hindbrain; drg, 
dorsal root ganglia; nt, neural tube; fl, forelimb; hl, hindlimb; sc, scapula; r, 
radius; u, ulna; a, autopod; pg, pelvic girdle; t, tibia; fi, fibula; PS, palate shelf
Additional file 2: Figure S2. Conditional removal of Shox2 using 
Nestin-Cre does not result in disruptions to the migratory programs 
of vMNs. (A) Diagram of a transverse section through rhombomere 4 
(r4) of the E11 brain highlights progenitors (red arrow, known to be 
Phox2b + [18]) and post-mitotic neurons (black arrow, region known 
to be Phox2b +/Isl1 + [18]) adjacent to the floor plate (fp) (image 
adapted from Pattyn et al. [18]). (B) ISH for Shox2 on an E11 transverse 
brain section through rhombomere 4 shows Shox2 expression in 
post-mitotic neurons (black arrow) but not in progenitors (red arrow). 
(C-E) ISH images from the Allen Brain Atlas database (http://www.
brain-map.org) show Shox2 (C, http://developingmouse.brainmap.
org/experiment/siv?i100082467&imageId = 101400047&initIm-
age = ish), Isl1 (D, http://developingmouse.brain-map.org/experiment/
siv?id = 100029096&imageId = 100647957&initImage = ish) and Phox2b 
(E, http://developingmouse.brain-map.org/experiment/siv?id=1000778
06&imageId=101287085&initImage=ish) expression in vMNs in sagittal 
sections at E11.5 (red arrows point to Phox2b + vMNs adjacent to the 
ventricular zone). (F-K) ISH on E11.5 serial sagittal sections through the 
hindbrain of control (F, H, J) and Nestin-Cre; Shox2flox/− mutant (G, I, K) 
embryos shows loss of Shox2 expression in the brain (compare F to G, 
arrows), while Isl1 (compare H to I, arrows) and Phox2b (compare J to K, 
arrows) expression is maintained in neurons migrating from the approxi-
mate rhombomere 4/5 (r4/r5) boundary to rhombomere 6 (r6), depicted 
using a red-dashed line. (L) Image of an E11.5 hindbrain sagittal section 
available from the Allen Brain Atlas database (http://atlas.brain-map.org/
atlas?atlas=181275741#atlas= 181275741&plate = 100425904&structure  
= 126651910&x = 5432&y = 2371&zoom = -2&resolution = 3.96&z = 6) 
indicates rhombomere divisions (r2 to r7) within the pontomedullary 
hindbrain (PMH). (M-R) ISH on E12.5 serial sagittal sections through the 
hindbrain of control (M, O, Q) and Nestin-Cre; Shox2flox/− mutant (N, P, 
R) embryos shows loss of Shox2 expression in the brain (compare M to 
N, arrow), while Isl1 (compare O to P, arrow) and Phox2b (compare Q 
to R, arrow) expression remain (approximate r5/6 boundary depicted 
using a red-dashed line). (S) Image of an E13.5 hindbrain sagittal section 
available from the Allen Brain Atlas database (http://atlas.brainmap.org/
atlas?atlas=181276130#atlas = 181276130&plate = 100793031&struc-
ture = 111220768&x = 4931&y = 2197&zoom = -2&resolu-
tion = 3.96&z = 6) indicates rhombomere divisions (r5 to r7). Scale 
bar = 500 μm
Additional file 3: Figure S3. Conditional removal of Shox2 using 
Nestin-Cre does not result in disruptions in palate development. (A, B) 
WISH on E12.5 control (A) and Nestin-Cre; Shox2flox/− mutant (B) embryos 
shows loss of Shox2 expression in parts of the developing trigeminal (V) 
ganglion (arrow), in addition to the developing maxillary process (mp, 
arrow) and mandibular arch (ma, arrow) in Nestin-Cre; Shox2flox/− mutants 
as compared to controls. (C, D) ISH on E12.5 sagittal sections through the 
hindbrain of control (C) and Nestin-Cre; Shox2flox/− mutant (D) embryos 
shows loss of Shox2 expression in the brain, including the facial motor 
nucleus (nVII, dashed-circle). (E) Representative image of P0 control (left) 
and Nestin-Cre; Shox2flox/− mutant (right) pups shows Nestin-Cre; Shox2flox/− 
animals with less milk in their stomachs as compared to controls (red 
arrows). (F-I) Coronal sections through the palate of control (F, H) and 
Nestin-Cre; Shox2flox/− (G, I) pups demonstrate that Nestin-Cre; Shox2flox/− 
animals have an intact palate (compare F to G and H to I, arrows). F and 
G are rostral sections, while H and I are more caudal sections through the 
palate. (J, K) Representative P0 control (J) and Nestin-Cre; Shox2flox/− (K) 
pup palates (viewed ventrally) show that Nestin-Cre; Shox2flox/− mutant 
animals have an intact palate. Abbreviations: ey, eye; cb, cerebellum; PS, 
palate shelf; PP. Scale bar = 500 μm
Additional file 4: Movie 1. Representative video of a P0 control and 
Nestin-Cre; Shox2flox/− mutant pup. This video highlights the different levels 
of physical activity of NestinCre-Cre; Shox2flox/− mutant pups (which are less 
active and display tremors) as compared to control pups, in addition to 
demonstrating that NestinCre-Cre; Shox2flox/− mutant pups have very little 
milk in their stomachs as compared to controls
Additional file 5: Figure S4. Conditional removal of Shox2 using 
Wnt1-Cre does not influence axonal projection properties of vMNs. (A, B) 
WISH on E12.5 control (A) and Wnt1-Cre; Shox2flox/− mutant (B) embryos 
show loss of Shox2 expression in the developing trigeminal (V) ganglion, 
in addition to the developing maxillary process (mp) and mandibular 
arch (ma). (C, D) Side view of the E12.5 face of control (A) and Wnt1-Cre; 
Shox2flox/− mutant (B) embryos stained with the 2H3 anti-neurofilament 
antibody show intact facial nerves (VII). Abbreviations: ey, eye. Scale 
bar = 500 μm
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